Tim Mullaney writes mostly on economics, health care and technology. He was national economics correspondent at USA Today from 2011 to 2014 and earlier served as E-Business Editor of BusinessWeek. Follow him on Twitter at @timmullaney.
As the US and Europe move to regulate Facebook amid privacy concerns, the social media giant's best bet may be continued growth in developing markets.
The most common knee surgery performed on seniors is for a meniscus tear. It's not only costly, it often doesn't work.
Gender affirmation surgery is becoming a reality for 1.4 million American trans people as work health insurance and Obamacare coverage bring down the cost of a sex change.
If Trump slaps $60 billion worth of tariffs on China today, it could retaliate against major U.S. exports, such as Boeing, a darling of the Dow.
Doctors at Johns Hopkins are proposing a new, earlier way to identify potential colon cancer patients that is less invasive and simpler than a colonoscopy.
If Trump slaps $60 billion worth of tariffs on China, it could retaliate against major U.S. exports, such as Boeing, a darling of the Dow.
Warren Buffett's Berkshire Hathaway surprised the market with a stake in Israeli drug company Teva. But it could be a classic value stock.
Nicolas Dujovne told CNBC on Thursday that the country was working to get out of a cycle of booms and busts.
The world's top stock market is in Argentina, with a 77 percent gain in 2017 and a businessman-president, Mauricio Macri, in control.
Now market experts are worrying about moves by President Donald Trump in 2018 that could upend the bull run in emerging markets.